Hormonal contraception and migraine: Clinical considerations

Stephanie S. Faubion; Petra M. Casey; Lynne T. Shuster

doi:10.1007/s11916-012-0278-7

Hormonal contraception and migraine: Clinical considerations

Stephanie S. Faubion, Petra M. Casey, Lynne T. Shuster

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive age may not only benefit from the use of hormonal contraceptives for contraception, but also for the purpose of reducing the burden of menstrual-related migraine. Although migraine is associated with an increased risk of stroke, the use of low-dose hormonal contraceptives in otherwise healthy women does not appear to confer additional risk.

Original language	English (US)
Pages (from-to)	461-466
Number of pages	6
Journal	Current pain and headache reports
Volume	16
Issue number	5
DOIs	https://doi.org/10.1007/s11916-012-0278-7
State	Published - Oct 2012

Keywords

Combined hormonal contraceptive
Estrogen
Menstrual migraine
Migraine
Oral contraceptive
Stroke

ASJC Scopus subject areas

Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1007/s11916-012-0278-7

Cite this

@article{794b71aa2a2a4543857f6d252625088f,

title = "Hormonal contraception and migraine: Clinical considerations",

abstract = "Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive age may not only benefit from the use of hormonal contraceptives for contraception, but also for the purpose of reducing the burden of menstrual-related migraine. Although migraine is associated with an increased risk of stroke, the use of low-dose hormonal contraceptives in otherwise healthy women does not appear to confer additional risk.",

keywords = "Combined hormonal contraceptive, Estrogen, Menstrual migraine, Migraine, Oral contraceptive, Stroke",

author = "Faubion, {Stephanie S.} and Casey, {Petra M.} and Shuster, {Lynne T.}",

year = "2012",

month = oct,

doi = "10.1007/s11916-012-0278-7",

language = "English (US)",

volume = "16",

pages = "461--466",

journal = "Current pain and headache reports",

issn = "1531-3433",

publisher = "Current Science, Inc.",

number = "5",

}

TY - JOUR

T1 - Hormonal contraception and migraine

T2 - Clinical considerations

AU - Faubion, Stephanie S.

AU - Casey, Petra M.

AU - Shuster, Lynne T.

PY - 2012/10

Y1 - 2012/10

N2 - Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive age may not only benefit from the use of hormonal contraceptives for contraception, but also for the purpose of reducing the burden of menstrual-related migraine. Although migraine is associated with an increased risk of stroke, the use of low-dose hormonal contraceptives in otherwise healthy women does not appear to confer additional risk.

AB - Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive age may not only benefit from the use of hormonal contraceptives for contraception, but also for the purpose of reducing the burden of menstrual-related migraine. Although migraine is associated with an increased risk of stroke, the use of low-dose hormonal contraceptives in otherwise healthy women does not appear to confer additional risk.

KW - Combined hormonal contraceptive

KW - Estrogen

KW - Menstrual migraine

KW - Migraine

KW - Oral contraceptive

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84870568144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870568144&partnerID=8YFLogxK

U2 - 10.1007/s11916-012-0278-7

DO - 10.1007/s11916-012-0278-7

M3 - Article

C2 - 22648178

AN - SCOPUS:84870568144

SN - 1531-3433

VL - 16

SP - 461

EP - 466

JO - Current pain and headache reports

JF - Current pain and headache reports

IS - 5

ER -

Hormonal contraception and migraine: Clinical considerations

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this